Analyze Diet

Efficacy of ivermectin in injectable and oral paste formulations against eight-week-old Strongylus vulgaris larvae in ponies.

Abstract: A controlled test method was used to evaluate the efficacy of injectable micelle and oral paste formulations of ivermectin (22,23-dihydroavermectin B1) against 8-week-old Strongylus vulgaris larvae in experimentally infected pony foals. The dosage level of the drug in both formulations tested was 0.2 mg/kg. Ponies were euthanatized and necropsied 5 weeks after treatment. Based on the recovery of live vs dead S vulgaris from mesenteric arteries, both formulations were greater than 99% effective. Increased weight gains and marked reductions in the severity of arterial lesions were observed in treated ponies.
Publication Date: 1984-01-01 PubMed ID: 6546649
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Comparative Study
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research article explores how effective injectable and oral paste formulations of ivermectin are against eight-week-old Strongylus vulgaris larvae in young ponies. The study found both formulations to have an effectiveness of over 99%, resulted in weight gains and reduced arterial lesions in the treated ponies.

Research Methodology

  • A meticulous test control method was employed to assess the effectiveness of injectable micelle and oral paste formulations of ivermectin – a popularly used deworming agent (scientifically known as 22,23-dihydroavermectin B1).
  • This study was primarily focused on combating eight-week-old Strongylus vulgaris larvae. These parasites are a type of large strongyle or bloodworm typically found in equines, which can lead to severe damage to the circulatory system of host animals.
  • The dosage level of ivermectin was uniformly dispensed at 0.2 mg/kg, ensuring a fair comparison between the effects of the injectable and oral paste formulations.
  • Following the treatment, the pony foals were euthanized, and a necropsy (autopsy on animals) was carried out after five weeks to evaluate the actual impact of the drug on the parasites.

Findings of the Study

  • The assessment was mainly based on the recovery of live versus dead S vulgaris from the mesenteric arteries. The mesenteric arteries are a group of arteries supplying the small intestine of animals. This is a common site of infestation for S vulgaris.
  • The findings revealed that both the injectable micelle and oral paste formulations of ivermectin registered an efficacy rate higher than 99%. This indicates that the drug was extremely effective in killing the S vulgaris larvae.
  • Furthermore, the research noted an increase in weight gains in treated ponies. This is a positive indicator as parasitic infections often lead to poor weight gain or even weight loss due to damage caused to the internal organs of the host animals. Successful deworming treatments can thus lead to better weight gain.
  • Significantly, the study also highlighted a marked reduction in the severity of arterial lesions in treated ponies. This is an important factor as S vulgaris larvae are known to cause physical damage to the artery walls, often resulting in arterial blockage, thrombosis, or aneurysm. A reduction in arterial lesions, therefore, indicates a successful neutralization of the larvae.

Cite This Article

APA
Klei TR, Torbert BJ, Chapman MR, Turk MA. (1984). Efficacy of ivermectin in injectable and oral paste formulations against eight-week-old Strongylus vulgaris larvae in ponies. Am J Vet Res, 45(1), 183-185.

Publication

ISSN: 0002-9645
NlmUniqueID: 0375011
Country: United States
Language: English
Volume: 45
Issue: 1
Pages: 183-185

Researcher Affiliations

Klei, T R
    Torbert, B J
      Chapman, M R
        Turk, M A

          MeSH Terms

          • Administration, Oral
          • Animals
          • Anthelmintics / administration & dosage
          • Anthelmintics / pharmacology
          • Horses
          • Injections, Intramuscular / veterinary
          • Ivermectin
          • Lactones / administration & dosage
          • Lactones / pharmacology
          • Larva / drug effects
          • Micelles
          • Ointments
          • Strongyle Infections, Equine / drug therapy
          • Strongyle Infections, Equine / parasitology
          • Strongyloidea / drug effects

          Citations

          This article has been cited 4 times.
          1. Nielsen MK, Scare J, Gravatte HS, Bellaw JL, Prado JC, Reinemeyer CR. Changes in Serum Strongylus Vulgaris-Specific Antibody Concentrations in Response to Anthelmintic Treatment of Experimentally Infected Foals.. Front Vet Sci 2015;2:17.
            doi: 10.3389/fvets.2015.00017pubmed: 26664946google scholar: lookup
          2. Bonneau S, Maynard L, Tomczuk K, Kok D, Eun HM. Anthelmintic efficacies of a tablet formula of ivermectin-praziquantel on horses experimentally infected with three Strongylus species.. Parasitol Res 2009 Sep;105(3):817-23.
            doi: 10.1007/s00436-009-1460-7pubmed: 19488785google scholar: lookup
          3. Slocombe JO, Cote JF. Effectiveness of ivermectin paste for removal of nematodes in the horse.. Can Vet J 1984 Oct;25(10):386-8.
            pubmed: 17422461
          4. Slocombe JO, McCraw BM, Pennock PW, Ducharme N, Baird JD. Strongylus vulgaris in the tunica media of arteries of ponies and treatment with ivermectin.. Can J Vet Res 1987 Apr;51(2):232-5.
            pubmed: 3607653